endogenous biomarkers and different types of metabolites
Conditions
Interventions
Group 1: Blood samples, saliva samples and urine samples of the participants are collected. Afterwards, these samples should be used as references for the development of new analytical methods in Clin
Sponsors
Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie der Friedrich-Alexander-Universität Erlangen-Nürnberg
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: written informed consent
Exclusion criteria
Exclusion criteria: medical contraindication against the planned type of sample collection, clinical relevant anemia, clinical relevant abnormalities of the urinary tract, clinical relevant abnormalities of the mouth or the salivary glands, acute diseases, pregnant or breast-feeding women, employees of the department of Clinical Pharmacology at the Friedrich-Alexander-Universität Erlangen-Nürnberg, students still having to take exams at the department of Clinical Pharmacology (especially students studying medicine, dentistry, molecular medicine, pharmacy or medical process management)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Building up a collection of standardized obtained reference samples (blood, saliva, urine) for the development and validation of new analytical methods in Clinical Pharmacology | — |
Secondary
| Measure | Time frame |
|---|---|
| see Primary Outcome | — |
Countries
Germany
Contacts
Public ContactArne Gessner
Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie der Friedrich-Alexander-Universität Erlangen-Nürnberg
Outcome results
None listed